Prices delayed by at least 15 minutes | Print


CVS HEALTH Corp (CVS)

Common Stock
Sell: $78.96|Buy: $79.75|Change: 0.33 (0.42%)

Open 

$79.54


Previous close 

$79.43


Trade high 

$80.75


Volume 

8,981,310


Year high 

$83.25


Year low 

$64.41


Dividend yield 

3.12%


Market capitalisation 

$100.37 bn


P/E ratio 

12.28


ISIN 

US1266501006


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Dividends

PreviousLatest
Record date22/01/202422/04/2024
Ex-dividend date19/01/202419/04/2024
Payment date01/02/202401/05/2024
Amount$0.665$0.665

Performance 31/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
CVS HEALTH Corp+ 0.42
More...

Company profile

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.